Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

NCT04170153 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic or Locally Advanced Unresectable Solid Tumors

Interventions

DRUG: M1774
DRUG: Niraparib

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]